- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02700061
Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity (NARLE1)
Effects of Upper Limb Motor Training and Upper Limb Robotic Training Over Neuroplasticity and Function Capacity: A Single-blind Randomized Clinical Trial With Patients With Stroke Sequelae
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since February 2012. The investigators are including patients with clinical diagnosis of Ischemic or hemorrhagic stroke.
The patients are being randomized in blocks of four, six and eight, in two arms: ICT: patients are undergoing 60 minutes physiotherapy and occupational therapy twice a week for ten consecutive weeks. Other therapeutic services as phonoaudiology, psychology, nutrition, physical conditioning are prescribed upon the patients' medical demands. After the 10 weeks, the patients are undergoing two whole weeks of daily ICT as to reach 90% of the time under constraint, including weekends. During this last period, no other therapeutic service is offered, but the occupational therapy under ICT. Patients are not allowed to undergo robotic therapy.
Robotic therapy: patients are undergoing robotic occupational therapy for 60 minutes, three times a week for twelve consecutive weeks. All other therapeutic services are prescribed upon the patients' medical demands. Patients are not allowed to undergo ICT.
The investigator and the raters are blind to treatment.
The evaluations are done prior to the beginning of the treatment and at the end of it. The follow up assessments are done at 3 and 12 months after the end of the treatment.
The sample size was estimated to be 62 patients in each arm, a total size of 124 patients
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Faza 2
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Sao Paulo, Brazylia, 04116-040
- Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Clinical diagnosis of stroke;
- Patients from 6 months after stroke up to 36 months after stroke;
- Clinically stable;
- Upper limb Brunnstrom scale III or IV;
- Brunnstrom scale above V if clinician supports patients will benefit from treatment;
- Minimum wrist extension of 20°, and minimum of 10° of metacarpophalangeal active extension.
- Signed Informed Consent Form;
Exclusion Criteria:
- Mini-Mental score lower than 20 points;
- Previous multiple strokes;
- Bone diseases and articulation injuries ;
- Presence of psychological disturbances capable of diminishing adherence;
- Articulation pain within the range of motion proposed by the therapies;
- Participation in another study protocol for upper limbs therapies.
- Previous treatment with robotic assisted therapies.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Induced Constraint Therapy - ICT
Physical rehabilitation with Induced Constraint Therapy as part of the occupational therapy.
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
|
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Inne nazwy:
|
|
Eksperymentalny: Robotic occupational therapy
Physical rehabilitation with Robotic occupational therapy.
Robotic Occupational Therapy three times a week for twelve weeks.
|
Robotic Occupational Therapy three times a week for twelve weeks.
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change on Motor Function assessed by Wolf Motor Function scale
Ramy czasowe: Baseline and 12 weeks
|
Change from baseline in Wolf Motor Function scale.
|
Baseline and 12 weeks
|
|
Change on Motor Function assessed by Fugl Meyer scale
Ramy czasowe: Baseline and 12 weeks
|
Change from baseline in Fugl Meyer scale.
|
Baseline and 12 weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change on Motor Function assessed by Wolf Motor Function scale
Ramy czasowe: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Wolf Motor Function scale.
|
Baseline, 3 months and 12 months
|
|
Change on Motor Function assessed by Fugl Meyer scale
Ramy czasowe: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Fugl Meyer scale.
|
Baseline, 3 months and 12 months
|
|
Change on Motor Function assessed by Robotic scale
Ramy czasowe: Baseline, 3 months and 12 months
|
Multiple changes from baseline in robotic scale.
|
Baseline, 3 months and 12 months
|
|
Change on Function ability and quality of movement assessed by Arm Motor Ability Test (AMAT)
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in AMAT scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Functional Independence Measure (FIM) as assessed by FIM scale
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in FIM scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Quality of life assessed by Stroke Impact Scale (SIS)
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in SIS.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Change on Kinematic variables assessed by InMotion robots
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple motion changes from baseline in the Kinematic variables assessed by InMotion robots.
|
Baseline, 12 weeks, 3 months and 12 months
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Psychological Evaluation assessed by Perceived Stress Scale (PSS-10)
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in PSS-10.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Neuroplasticity as assessed by Brain Derived Neurotrophic Factor (BDNF)
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in BDNF.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Corticospinal excitability as assessed by transcranial magnetic stimulation (TMS)
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in TMS.
|
Baseline, 12 weeks, 3 months and 12 months
|
|
Neurologic evaluation as assessed by electroencephalography
Ramy czasowe: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in electroencephalography.
|
Baseline, 12 weeks, 3 months and 12 months
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Linamara Rizzo Battistella, Md PhD, University of Sao Paulo
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 0910.0.015.000-11
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .